chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has myocarditis/pericarditis with pericardial and pleural effusions after receiving the Pfizer COVID-19 booster vaccine on 9/24/2021 requiring hospitalization. Symptoms include chest pain, shortness of breath, fevers, and fatigue. Symptom onset approximately 7-10 days after receiving  booster shot.
Face became itchy 15 min after vaccination. Given 25mg BENADRYL ELIXIR PO after 30 min no itchiness felt by patient. Waited another 10 min. Sent home told to call 911 if symptoms return.
Approx. 11 hours, post vax, pt awoke with fever, vomited and was unresponsive X 20 minutes. Taken to ER by EMS. Discharged to home without further incident while in the hospital. Have been unable to reach at home. Diagnosed with seizure.
had tinnitus from blood flow; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (had tinnitus from blood flow) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (preexisting health problems).    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (had tinnitus from blood flow). At the time of the report, TINNITUS (had tinnitus from blood flow) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication was reported.  It was told by doctor that event can occurred due to COVID-19 infection or the immunization.  No treatment medication was reported.
Severe Abdominal cramping, diarrhea, nausea and chills.
Swelling and redness at injection site - area of swelling 3" x 4", area of redness and itching 2" x 3"; lethargy and fatigue beginning 6/2/20; headache beginning around noon 6/2/20; upset stomach beginning 10pm on 6/1/20;  shivering and fever beginning about 5pm on 6/2/20; fever spiked to 102.4 at 8 pm 6/2/20; additional ibuprofen broke fever 11:30 pm; some lingering fatigue and muscle ache on 6/3/20.
patient stated severe arm pain started 4 hours after the vaccine tendonitis feeling patient was seen in followup  app't on March 30, 2023 with Dr.
Herpes Zoster with Opthalmic complications; This initial spontaneous report was received from a lawyer regarding a case in litigation and referred to a currently 78 years old male patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unknown date in 2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dose, dose number and route not specified) for prophylaxis. On an unspecified date, the patient experienced Herpes Zoster with Opthalmic complications. On an unspecified date, the patient was treated by a physician for Herpes Zoster with Opthalmic complications. The outcome of the events Herpes Zoster with Opthalmic complications was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event ophthalmic herpes zoster was determined to be medically significant.  Additional information has been requested.
Pain, soreness in Right Arm.  Moderate to severe flu-like symptoms, including fever, chills, aches, extreme fatigue, dizziness and nausea.  The symptoms persisted 36-40 hours after taking the vaccination.  I experienced similar symptoms shortly after my first vaccination in March, 2019.   However those flu-like symptoms were far less pronounced than after the second vaccination.  I missed two days at work because of the side affects of this vaccine.  My wife, who was vaccinated on the same day, still has not recovered.  She did see a doctor.
PATIENT STATED THAT HER RIGHT ARM WAS IN SEVERE PAIN AND NUMB EVER SINCE HER FLU SHOT, REPORTED NUMBNESS THAT EXTENDED TO THE TORSO AND INTO THE RIGHT SIDE OF THE NECK. SHE DECLINED THE RECOMMENDATION TO SEE A CAREGIVER.
Pt reports felt short of breath 10-15 minutes after leaving clinic - went to hospital ER. Pt states she had "extreme anaphylactic shock". Pt. states she was transferred to hospital where she stayed for 4 days. Home on 10/19. Still very tired and remains short of breath - on steroids & inhalers - being followed by her primary physician.  11/4/09 Hospital records received service dates 10/15/09 to 10/18/09. Assessment: Allergic reaction to FluMist with anaphylaxis. Pleurisy with pleuritic chest pain. Asthma, acute exacerbation. Urinary tract infection, E. Coli. Patient became extremely short of breath 10-15 minutes after receiving nasal flu vaccine. Sharp left-sided chest pain. Hoarse. Difficulty swallowing. Alternate sweating and feeling cold. Diminshed breath sounds. Morbid obesity. Tobacco abuse disorder.
Initially nerve pain from left neck to left fingers lasting 12 hours. Woke up with a migraine. Have had nearly daily headaches or migraines ever since. Previous to vaccination I would get one or two migraines per month. I also had joint pain in joints previously affected by Lyme disease 9 years ago that hadnt bothered me since being treated. That lasted about 6 weeks and has now finally subsided.
I began feeling ill I exercised hoping to feel better then around eight PM I went I tested myself because I felt feverish I fainted and i my husband had to carry me to bed I had a temperature of one hundred and one point eight I had high blood pressure besides and a horrible horrible headache and a sore throat and I had to stay in bed the whole night an horrible horrible upper respiratory congestion.  I took Pacxlovid.  I had a rebound case on 20FEB2022 with similar  symptoms.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium
flu both times; Initial information received on 09-Oct-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health care professional..  This case involves adult patient (unknown age and gender) who experienced flu both times (influenza), while receiving vaccine INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient's medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a two doses of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu both times (influenza) (unknown latency) following the administration two doses of INFLUENZA VACCINE.  It was reported "I have had the flu shot twice and got the flu both times. No amount of convincing will get me to take it again".  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
AS SOON AS CHILD GOT HOME HAD SLT HA, THEN SPIKED A FEVER OF 101 PROCESSED BY GENERALIZED BODY ACHES ON EVENING OF 08/23/2016 BODY ACHES CONTINUED NEXT DAY BUT FEVER RESOLVED. KEPT HOME FROM SCHOOL. 08/25/16 SLT BODY ACHES REMAIN, FEVER RESOLVED CHILD BACK TO SCHOOL TODAY.
This spontaneous report was received from a 57-year-old female patient regarding herself. The patient had none pertinent medical history and none drug reactions or allergies. The patient's concomitant therapies included tizanidine and gabapentin. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23, (dose, route, anatomical location, lot number and expiration date were not reported) for prophylaxis. The patient did not experience any adverse effects except for a minor temporary soreness at the injection site which was recovered on an unspecified date. Then, on 13-OCT-2017, the patient was vaccinated with the second dose of PNEUMOVAX 23, one shot, injected, (anatomical location, lot number and expiration date were not reported) for prevention of pneumonia. Since 13-OCT-2017, the patient had been experiencing severe pain, swelling, heat, and weakness in her arm. After received the vaccination, the patient went to Emergency Room; she was not admitted to the hospital but she received treatment with MICARDIS, unspecified antibiotics and unspecified steroid. No laboratory diagnostics were performed. At the time of the report, the patient did not recover from the severe pain, furthermore, it was causing her on unspecified date to cry frequently and often prevented her from sleeping at night. Additionally, in 2017 the patient could not raise her arm because of how badly her arm hurt. The outcome of the muscular weakness, injected limb mobility decreased, peripheral swelling, feeling hot, insomnia and crying was unknown. The relatedness between the events and therapy with PNEUMOVAX 23 was not reported.
Fully vaccinated, not boosted.   Inpatient stay after asymptomatic COVID breakthrough infection
1st dose of Pfizer at 08:17 and was walked to observation area. It was noted by EMT on-site that she  stated at the end of her observation time that she was very light headed and the room was spinning. She did not feel comfortable walking at the end of her observation time.  At 08:46, call placed to outside EMS by EMT on-site had initiated direct transport to ED per patient's request. Patient stated she just flew home from Florida last night so she is wondering if she may be dehydrated or maybe even anxious about the shot.  Patient stated she would feel better being monitored in the ED to make sure she is fine.    History of: Anaphylaxis to Tetanus Toxoid  Nursing Assessment:  Airway: Open Breathing: Spontaneous Circulation: Pulse present, Mentation: Alert, Oriented x 3 Skin: Normal  Patient monitored., Vital signs obtained and recorded. and Oxygen saturation level obtained.  0853: BP 181/98, HR 61, RR 14, non-labored  0855: BP 178/103, HR 70, RR 16, non-labored 0858:  BP 174/100, HR 58, RR 16, non-labored Oxygen saturation was 99-100% on room air and was continually monitored until ambulance arrival.  Patient was given water and was able to walk independently with stand-by assistance to get onto ambulance stretcher despite stating she was still dizzy and the room was spinning.       She was transported to the emergency department via ambulance at 0910.
Case number PHEH2014US025085, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 90-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 24 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Blinking/shuttering noise in her brain; Vomiting; Nausea; Chills; Fever; A spontaneous report (United States) was received from a consumer concerning a 77-year old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced vomiting, nausea, chills, fever and blinking/shuttering noise in brain.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 15 Jan 2020, approximately 12 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number 702195013L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 16 Jan 2020, about 12 hours following vaccine administration, the patient experienced vomiting, nausea, chills and fever that lasted for 48 hours. She also began hearing a blinking/shuttering noise in her brain. Treatment for the event included paracetamol, ibuprofen, and emetrol.  Action taken with mRNA-1273 in response to the events was not reported.  The events vomiting, nausea, chills and fever, were resolved on 18 Jan 2021. The outcome of the event blinking/shuttering noise in brain was unknown.; Reporter's Comments: This case concerns 77-year old, female patient who experienced non-serious expected events of vomiting, nausea, chills, fever and non-serious unexpected event of blinking/shuttering noise in brain. The events occurred about 12 hours after the first dose of mRNA-1273 vaccine.  Treatment for the events included paracetamol, ibuprofen, and emetrol. Vomiting, nausea, chills, fever resolved, however outcome of blinking/shuttering noise in brain was reported as unknown.  All events were assessed as related to mRNA-1273 vaccine due to temporal association.
Really bad fever, stomach aches. Really bad sweating, muscle aches, little headache. Fainted for a few seconds. Felt heart area hurting
10/18/04: Coryza, fever, progressed to full blown rubeola with petechiae and Koplik spots. Mother with coryza and conjunctivitis (status post MMRI).
lightheaded/instability, headache, leg weakness, brain fog, increased hearing loss, increased tinnitus, decreased equilibrium, fatigue, tremors, orthostatic hypotension, inability to stand still/rocking, in and out blurred vision, unsteadiness, loss of balance, mis stepping, sensation of falling
Pt rec'd Influenza Immunization at 930 am. At 1005 pt complains of swollen tongue and shaky handwriting. Pt escorted to MD. 10:20 am  VS: 98.3 degrees BP 230/130 HR 94 O2 99% RA. Dr. ordered med admin by RN 1020 am SOLUMEDROL 125 mg IM x 1. 10:23 am BENADRYL 20 mg IM x 1 by RN, 1025 BP: 220/110 felt decreased tingling & swelling of tongue 1040 EMS arrive & transport pt to hospital.
No adverse event; patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine).    No concomitant medications were reported.  The patient received monovalent Moderna Covid-19 vaccine instead of Moderna bivalent vaccine. Lot 057A22A expiration date February 6, 2023,  No treatment drugs were reported.
pt recvd vax 230PM on 23AUG93 was fed @ 4PM placed on side on the couch by mom; pt spit up & turned blue; mom says was not breathing @ that time; tried back blows which resulted in gasping once; called 911;
Pt. tolerated vaccines well in office. The next day went to ER with C/O redness and swelling in (R) leg-knee-area. I spoke with ER Nurse, she states it was a localized reaction from Dtap. 05/03 08:59 This 5 yrs old Male presents to Ed via POV with complaints of Allergic Reaction. 5 yo male received 4 vaccines yesterday morning at 0900, two in right leg and two in left leg. Patient acted normally all day, then began complaining of right leg pain yesterday evening. He can walk on his leg, but it hurts. The pain is located near the injection site and in his knee. He has associated swelling in this knee and entire leg. There is a small red rash at the injection site. No other assoc Sx including F/C, N/V/D, cough, SOB, or other rashes. He has never had reactions to vaccines before.
injection site pain; Redness / dime-sized surrounding the injection site; sore arm; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 76-year-old female patient who received Herpes zoster (Shingrix) (batch number PR5B2, expiry date 8th November 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On 18th November 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 18th November 2019, 5 hrs after receiving Shingrix, the patient experienced injection site pain, injection site erythema and pain in arm. On an unknown date, the outcome of the injection site pain, injection site erythema and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient receive the 2nd dose of Shingrix vaccine and after 5 hours, she experienced injection site pain, redness, and a sore arm. The redness was described as dime-sized surrounding the injection site. The site was still red and the arm  was still sore 1 week after the injection and at time of report. There was no adverse event reported for the 1st dose of Shingrix vaccine. The reporter consented to follow up.
Patient received 3 pfizer covid vaccines on 2/2/21, 2/23/21, and 10/25/21. Patient had cardiology visit on 11/4/21 due to recent episode of chest pain in the setting of an upcoming marathon participation. On 10/28/21, patient experienced a sudden-onset, left-sided, pressure like chest pain of 8/10 in severity and went to the ED.  Troponin on 10/28: 32-- >33-> 31 11/4: 32  CRP: 1.7  cardiac mri done on 11/5/21: Normal biventricular function. The pattern of late gadolinium enhancement is most likely secondary to myocarditis. Cardiac sarcoidosis is considered unlikely given the absence of arrhythmia or evidence of extracardiac sarcoidosis.
This is a spontaneous report from a contactable consumer who reported for his 2 daughters. These patients experienced the same events after first and second dose of vaccine. This is the first of 2 reports for patient 1. A 20-year-old female patient received, on 05Jun2015, the first single dose of TRUMENBA. The patient had ongoing asthma chronic and allergy for entire life. Concomitant medications included birth control pills and inhaler as needed for asthma. On 05Jun2015, the patient experienced minimal pain at the injection site. No treatment was provided. Laboratory tests were not performed. The patient recovered on 05Jun2015. The same reaction occurred to her sister after first vaccination with MenB performed on 05Jun2015. Follow up (07Aug2015): New information received from the same contactable consumer includes: details of patient. Follow-up (13-SEPT-2015): Follow-up attempts are completed. No further information is expected.
Records review utilized to obtain information:  Pt recieved his first dose of the Pfizer COVID-19 vaccine on 1/27/2021, unable to determine location that administered vaccine.  Pt called to his PCP and indicated he was experiencing "intense, but intermittent stomach pain in the LUQ since the day after receiving vaccine.  He stated he was not eating due to the pain, and that nausea and vomiting would occur when eating.  His wife and son both tested positive for COVID-19 per PCR on 1/29 (unknown what type of test).  He was tested on 1/25 prior to vaccination and was negative at that time.  He ended up going to the ER later that day and is recorded as having a fever and cough at that time, in addition to the pain as described above.  Pt tested positive at this time on admission testing (2/5/2021).  He is still currently inpatient at our facility.
Pain MRI 10/22/07, surgery 10/24/07 LETTER FROM PATIENT ATTACHED; I received a flu shot at pharmacy on Oct 2 2007, By the Pharmacist. The shot was given Very High in the left arm, I said that felt like you hit bone, she said well I would know if I hit bone. My arm was a little sore for a couple of days witch I expected is something Normal even in the past. I've gotten flu shots before no problem. But this hurt bad even after a few days and continue to get worse and worse I couldn't sleep and move my arm with out some great pain so my husband and I decided it was time to go to the doctor and see what he would say. I went to the Dr. on 10-18-07 he sent me for a M.R.I. on 10-22-07 Then sent me to a Orthopedic Specialist on 10-23-07 and the results were remove the and clear Liquid inside a bursa  and scope surgery on 10-24-07 at 430 pm.
Information has been received from a caller concerning her daughter a 17 year old who became very ill after receiving injection the first dose of GARDASIL on 01-MAY-2008. There was no concomitant medication. She had a fever, nausea, dizziness, and pain on the entire length of the arm where the injection was given. The patient sought medical attention and the outcome was unknown. No further information is available.
Flu-like symptoms; Bruise at the injection site; Fever; Nausea; Muscle aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Muscle aches) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue) had resolved.            No, Concomitant medication was provided. No, Treatment was provided. Patient had the first dose of the Moderna COVID-19 vaccine on 18May2021 (lot # 033C21A).  Immediately after the shot, the patient felt flu-like symptoms, nausea, muscle aches, and fatigue. These got better after about 2 days.   This case was linked to MOD-2021-224140 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received on 30 Jul 2021, Updated the outcome for the events.
Left sided facial numbness 36 hours Dizzy spells 36 hours Fatigue 58 hours and counting body aches 48 hours  headache 36 hours stabbing pain 36 hours